The strength of personal relationships and social connections are the most important factors for accessing capital markets according to a recent working paper from the National Bureau of Economic Research (NBER).

Many of the most successful technology, life science and advanced companies in the country received financing in the form of an equity investment during their rapid growth and scaling stages of development.  Whether viewed as valiant, villains or vultures, the presence of individuals and firms willing to provide capital to companies when they have few physical assets or revenues is strongly associated with healthy regional innovation economies. As a result, considerable policy attention has been focused by states on increasing the amount of risk capital flowing to local startups.

Having interdisciplinary teams of scientists and relationships with “star” entrepreneurs are factors that can influence the chances for academic discoveries to reach the commercialization stage. While proximity to capital has traditionally been viewed as the core stimulus for academic commercialization, a recently released working paper by the National Bureau of Economic Research reexamines the variables that play a role in the commercialization of academic sciences, and provides new insight into the importance of team composition throughout the commercialization process.

Disruptive technology, or innovations that radically alter the way consumers, industry, or businesses operate, have long been thought to be the primary way emerging small firms can leapfrog competition and compete against large industry titans. Through innovations such as internal IT systems or logistical improvements, small firms can acquire a decisive competitive advantage over their rivals. Or so the traditional theory holds. In a new paper out of Boston University School of Law, Bessen et al.

A recent study exploring the science underlying all 356 pharmaceutical drugs approved by the Center for Drug Evaluation and Research since 2010, found each drug is based on life science investments the public sector has made through the National Institutes of Health (NIH).

The early days of vaccinating against the coronavirus might not be the most receptive time to raise issues of antitrust in the U.S. pharmaceutical industry, but a November 2020 Barcelona GSW Working Paper raises several concerns about the degree and effect of common ownership within big pharma. Does this explain the resistance of drug prices to fall? Should Congress take on the likes of brand firms Johnson & Johnson, Merck and Pfizer, in addition to already challenging the tech giants, in 2021?

If you are feeling that your money is not buying as much as it used to, that delinquent crime may be increasing as teenagers sit idle, that there is not enough focus on climate change or that corporate responsibility may be lacking, you may validate those feelings through the findings of several recently released research papers. SSTI received notice of the conclusions of five working papers that we thought we’d share.

The Trade War is increasing U.S prices, declines in real income.

Recent research revealed that exposure to innovation (e.g., mentorship program and immersive K-12 STEM education experience) during childhood and young adulthood has a greater effect on the decision to pursue careers in innovation than financial incentives. Researchers Alexander M. Bell, Raj Chetty, and their co-authors developed a model to analyze the impact of several factors on inventor career choices.

While competition between states over business incentives and headquarters attraction is often derided, new research published in the Journal of Technology in Society suggests that competition in technology-based economic development is hardly a zero-sum game.

In a recently revised working paper from the Center for International Development at Harvard University, the contemporary rise of populism is explained in a new light, that of unfair economic outcomes, often in the form of low social mobility.

A working paper from the Innovation Growth Lab (IGL) series featuring researchers from the Max Planck Institute for Innovation and Competition provides causal evidence on the effectiveness of innovation vouchers and adds to the argument for implementing small-scale government funding mechanisms like innovation vouchers.

Discussions surrounding automation’s power and the effect it could have on jobs have only increased over time. The current pandemic adds to the debate of whether automation and robotics, which are unaffected by viruses and have the potential for cost savings, could offer a safer bet for industries than human labor. Such are the debates the authors of a new working paper considered in their research examining jobs that were identified in the past as being at risk of elimination through automation.

“The Achilles Heel of Reputable VCs,” a recent paper by Nuri Ersahin et al., finds that the most successful venture capital (VC) funds make fewer and smaller investments in states after investment tax credits go into effect. These VCs also co-invest with fewer firms, are less likely to invest in “serial” entrepreneurs and experience fewer positive exits after the introduction of the tax credit.

The challenge of attracting and retaining skilled manufacturing talent consistently ranks as a top concern in the industry. Recent findings from the National Association of Manufacturers (NAM) show that more than 70% of industry leaders cite workforce issues as their primary challenge for the past year, outpacing supply chain disruptions and rising raw material costs.

Since 1980, billion-dollar climate disasters in the United States have increased an astonishing 749%, from averaging 3.3 throughout the 1980s to 28 in 2023 alone. These data from the NOAA National Centers for Environmental Information include floods, wildfires, droughts, severe storms, tropical cyclones, and winter storms.

A working paper by a team of Harvard-affiliated researchers presents challenging findings for growth equity impact investors. Given the potential alignment between this sector of the market and publicly funded capital access programs (including many venture development organizations and the State Small Business Credit Initiative), this research may find its way into public policy debates. The paper, which has not yet been published in an academic journal, also contains several shortcomings in its approach that should caution any stakeholders from acting on its findings alone.

Traditionally, a scientific discovery's commercial potential is gauged after significant R&D. However, a recent paper by Duke University researchers Roger Masclans-Armengol, Sharique Hasan, and Wesley M. Cohen (2024) proposes a new method for assessing the commercial potential of scientific research before it's fully developed.

In the last twenty years, there has been a critical shift in the technology transfer landscape that calls for a fundamental overhaul of university Technology Transfer Offices (TTOs) from focusing on passive IP management to active startup development, according to a recent SSRN article.

A recent Federal Reserve Bank of Kansas City working paper explores the relationship between inter-state mobility, earnings gains, and initial wealth of young college graduates over time, highlighting the impact of debt. The paper Should I Stay or Should I Go? Inter-state Mobility and Earnings Gains of Young College Graduates by Andrew Glover and José Mustre-del-Río proposes a model to explain the decline in mobility.

A recent National Bureau of Economic Research (NBER) working paper, Immigrant Entrepreneurship: New Estimates and a Research Agenda provides fresh insights into the growth and characteristics of immigrant-founded firms across the United States. The study also outlines directions for future research in this field.

Key findings from the authors’ statistical analysis include: